Sign Up to like & get
recommendations!
0
Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-46148-1
Abstract: The GM3(Neu5Gc) ganglioside represents a tumor-specific antigen that is considered a promising target for cancer immunotherapy. We previously demonstrated that the humanized antibody 14F7hT, specific for this ganglioside, exhibited significant antitumor effects in preclinical hematological…
read more here.
Keywords:
gm3 neu5gc;
ganglioside;
antibody;
antitumor effects ... See more keywords